(PharmaNewsWire.Com, October 01, 2020 ) The global advanced wound care market is expected to reach USD 16.5 billion by 2025 from USD 10.3 billion in 2020, at a CAGR of 9.8%. Market growth is primarily driven by the rapidly growing geriatric population, rising incidence of diabetes, technological advancements in wound care products, funding for wound care research, and growing awareness of wound management. On the other hand, the high cost of some wound care products and the risks associated with wound management may limit market growth to a certain extent.
The advanced wound care market is consolidated in nature. The major players operating in this market are Smith & Nephew Plc. (UK), Mölnlycke Health Care AB (Sweden), B. Braun Melsungen AG (Germany), ConvaTec Group (UK), Coloplast A/S (Denmark), Integra LifeSciences Holdings Corporation (US), 3M Group (US), Cardinal Health Inc. (US), Paul HARTMANN (Germany), Medline Industries (US), Lohmann & Rauscher (Germany), Advancis Medical LLC (UK), Organogenesis (US), MiMedx Group (US), DeRoyal Industries Inc. (US), Winner Medical Co. Ltd. (China), Kerecis (Iceland), Hollister Inc. (US), Shield Line (US), Welcare Industries SPA (Italy), Misonix (US), MilLaboratories Pvt. Ltd. (India), ACell (US), Zimmer Biomet (US), and DermaRite Industries LLC (US).
3M Group (US) is the largest player in the advanced wound care market. The company focuses on the development of dressings, devices, consumables and accessories required to delover advanced wound care for different types of wounds. The company recently acquired Acelity to strenghten its advanced wound care and wound care portfolios.
Smith & Nephew Plc. (UK) is a pioneer in the advanced wound care market. As a result, it has a strong foothold in the advanced woudncare market. The company manufactures and distributes advanced wound care dressings, devices, accessories, topical agents and other consumables. The comapny focusses on both organic and inorganic growth strategies.
About MarketsandMarkets™
MarketsandMarkets™ provides quantified B2B research on 30,000 high growth niche opportunities/threats which will impact 70% to 80% of worldwide companies’ revenues. Currently servicing 7500 customers worldwide including 80% of global Fortune 1000 companies as clients. Almost 75,000 top officers across eight industries worldwide approach MarketsandMarkets™ for their painpoints around revenues decisions.
Our 850 fulltime analyst and SMEs at MarketsandMarkets™ are tracking global high growth markets following the "Growth Engagement Model – GEM". The GEM aims at proactive collaboration with the clients to identify new opportunities, identify most important customers, write "Attack, avoid and defend" strategies, identify sources of incremental revenues for both the company and its competitors. MarketsandMarkets™ now coming up with 1,500 MicroQuadrants (Positioning top players across leaders, emerging companies, innovators, strategic players) annually in high growth emerging segments. MarketsandMarkets™ is determined to benefit more than 10,000 companies this year for their revenue planning and help them take their innovations/disruptions early to the market by providing them research ahead of the curve.
MarketsandMarkets’s flagship competitive intelligence and market research platform, "Knowledgestore" connects over 200,000 markets and entire value chains for deeper understanding of the unmet insights along with market sizing and forecasts of niche markets.
We are pleased to offer you this exciting, new, and entirely free professional resource. Visit our Free Biotechnology & Pharmaceuticals resource center today to browse our selection of 600+ complimentary Biotechnology & Pharmaceuticals magazines, white papers, webinars, podcasts, and more. Get popular titles including:
